ITMCTR2100004897Recruiting未知
Clinical Study in Fatigue State of Sub-health with Yang-deficiency Constitution with Interventions of Warming Needle Moxibustion
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine0 sitesStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional study
Eligibility Criteria
- Ages
- 18 to 60 (—)
- Sex
- All
Inclusion Criteria
- •1.Meet the diagnostic criteria of sub-health;
- •2.Meet the diagnostic criteria of yang deficiency;
- •3.Aged 18 to 60 years;
- •4.Gender is not limited;
- •5.No organic disease;
- •6.Informed consent and signed a consent form.
Exclusion Criteria
- •1.Patients with severe primary diseases such as cardiovascular, cerebrovascular, liver, kidney, hematopoietic system;
- •2.Patients with diabetes or mental illness;
- •3.Patients who do not understand the contents of the questionnaire well due to educational level and other reasons;
- •4.Breastfeeding, Women who are pregnant or who are about to become pregnant recently;
- •5.Patients have allergies;
- •6.Patients have severe skin ulcers and skin rashes are not suitable for moxibustion;
- •7.Patients are diagnosed with scars.
Investigators
Similar Trials
Recruiting
Not Applicable
A Study on the Characterization of Fatigue Patients after StrokeKCT0003900Kyung Hee University160
Not yet recruiting
Not Applicable
fatigue, and performance status in anaemic cancer patients undergoing cancer treatment.CTRI/2022/01/039371Aditi Sawant Dessai
Not yet recruiting
Phase 4
A pilot study to investigate whether fatigue is a side effect of etanercept in patients with moderate to severe psoriasispsoriasis10040785NL-OMON29881Academisch Medisch Centrum160
Completed
Not Applicable
Tiredness and its causes in patients with cancers which has spreadedCTRI/2018/01/011189AlIMS110
Completed
Not Applicable
A prospective observational study about fatigue in patients with unresectable pancreatic cancer who receive nab-paclitaxel plus gemcitabine therapyPatients with unresectable pancreatic cancerJPRN-UMIN000021758Wakayama Medical University10